MENU
FDMT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
4D Molecular Therapeutics (FDMT) Ownership - Who owns 4D Molecular Therapeutics?
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors... Show more
Profile
Industry
N/A
Address
5858 Horton Street
Phone
+1 510 505-2680
Employees
147
Web
https://www.4dmoleculartherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
157.43M
P/E Ratio
N/A
Total Cash
424.88M
Projected Growth
N/A
Total Debt
24.61M
Revenue
37K
Risk (Beta)
3.21
Dividend Yield
N/A
Total Cash/Share
9.18
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
FDMT
Capitalization
157M
P/E Ratio
N/A
Risk (Beta)
3.21
Dividend Yield
N/A
Total Cash
425M
Total Cash/Share
9.18
Total Debt
24.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
37K
ROE
N/A
Book Value
511M
P/B Ratio
0.31
Cash Flow
N/A
Earnings
-2.98
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
14.92
Current Revenue Per Employee
4.41
Dividends Per Share - Security
N/A
EBITDA
-181.14M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-35.74
Shares Held By Institutions
494M
Shares Outstanding - Current
46.3M
Total Liabilities
49.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
-38.779
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
5858 Horton Street
Phone
+1 510 505-2680
Employees
147
Web
https://www.4dmoleculartherapeutics.com